BioLife Solutions, Inc. (BLFS)

BioLife Solutions Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	66.95	95.39	27.9	19.44	69.86	90.4
Short-Term Investments	21.64	9.2	16.29	43.26	-	-
Cash & Short-Term Investments	88.58	104.58	44.18	62.7	69.86	90.4
Cash Growth	95.66%	136.70%	-29.53%	-10.25%	-22.72%	1302.03%
Receivables	9.17	9.17	7.9	33.94	23.22	8.01
Inventory	27.57	29.01	27.16	34.9	28.35	11.6
Prepaid Expenses	5.82	6	4.67	6.88	4.66	4.65
Restricted Cash	-	-	-	0.03	0.01	0.05
Other Current Assets	-	-	36.69	-	-	-
Total Current Assets	131.13	148.76	120.6	138.45	126.09	114.71
Property, Plant & Equipment	22.42	22.86	19.48	48.27	46.61	24.52
Long-Term Investments	20.05	5.62	5.62	6.4	4.37	5.87
Goodwill	212.3	212.3	212.3	224.74	224.74	58.45
Other Intangible Assets	8.86	9.56	12	32.09	152.15	31.05
Other Long-Term Assets	0.38	0.38	42.71	0.28	0.33	0.23
Total Assets	395.14	399.49	412.71	450.23	554.29	234.83
Accounts Payable	3.3	3.57	2.27	15.37	14.95	3.67
Accrued Expenses	12.03	16.6	13.22	12.36	8.6	3.37
Current Portion of Long-Term Debt	10.45	10.94	6.29	1.81	0.86	0.61
Current Portion of Leases	1.84	1.51	1.29	3.02	2.91	1.12
Current Income Taxes Payable	-	-	0.26	0.98	0.03	0.11
Current Unearned Revenue	0.12	0.1	0.04	0.55	0.81	0.93
Other Current Liabilities	-	-	18.82	10.5	14.55	5.76
Total Current Liabilities	27.72	32.73	42.18	44.58	42.7	15.57
Long-Term Debt	2.5	5	17.56	23.79	6.35	0.66
Long-Term Leases	12.17	12.72	8.7	15.09	16.76	8.77
Long-Term Deferred Tax Liabilities	0.13	0.12	0.11	0.25	5.49	-
Other Long-Term Liabilities	-	-	6.5	2.33	4.94	4.59
Total Liabilities	42.52	50.58	75.05	86.04	76.24	29.58
Common Stock	0.05	0.05	0.05	0.04	0.04	0.03
Additional Paid-In Capital	688.09	683.94	652.88	611.74	585.4	302.6
Retained Earnings	-335.55	-335.1	-314.92	-246.92	-107.11	-97.39
Comprehensive Income & Other	0.03	0.02	-0.35	-0.68	-0.28	-
Total Common Equity	352.62	348.91	337.66	364.19	478.05	205.25
Shareholders' Equity	352.62	348.91	337.66	364.19	478.05	205.25
Total Liabilities & Equity	395.14	399.49	412.71	450.23	554.29	234.83
Total Debt	26.95	30.17	33.83	43.71	26.88	11.15
Net Cash (Debt)	80.69	79.04	10.91	18.99	42.98	79.25
Net Cash Growth	1771.65%	624.79%	-42.57%	-55.82%	-45.77%	1459.73%
Net Cash Per Share	1.74	1.72	0.25	0.44	1.12	2.90
Filing Date Shares Outstanding	47.56	47	45.3	43.21	42.09	33.4
Total Common Shares Outstanding	47.55	46.91	45.17	42.83	41.82	33.04
Working Capital	103.41	116.03	78.43	93.87	83.39	99.14
Book Value Per Share	7.42	7.44	7.48	8.50	11.43	6.21
Tangible Book Value	131.46	127.05	113.36	107.36	101.16	115.75
Tangible Book Value Per Share	2.76	2.71	2.51	2.51	2.42	3.50
Machinery	13.42	13.88	13.8	30.14	24.18	14.15
Construction In Progress	6.14	5.58	5.16	6.75	4.42	2.54
Leasehold Improvements	3.59	3.53	3.5	5.25	3.84	2.39

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q